Mikhail E Shmelev

6PUBLICATIONS
14CO-AUTHORS
Molecular targetsCancer geneticsPredictive and prognostic markersGene and molecular therapyPolymers and plastics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 14, 2025
Therapy enhancing chromosome instability may be advantageous for IDH1 R132H/WT gliomas.

Nikolay V Goncharov, Ivan N Baklanov, Valeriia S Gulaia

|Nov 27, 2024
IDH1 R132H and TP53 R248Q Mutations Modulate Glioma Cell Migration and Adhesion on Different ECM Components.

Mikhail E Shmelev, Andrei A Pilnik, Nikita A Shved

|Jul 27, 2024
Rational Design of Pectin-Chitosan Polyelectrolyte Nanoparticles for Enhanced Temozolomide Delivery in Brain Tumor Therapy.

Vladimir E Silant'ev, Andrei S Belousov, Fedor O Trukhin

|Feb 25, 2023
Nanomechanical Signatures in Glioma Cells Depend on CD44 Distribution in IDH1 Wild-Type but Not in IDH1R132H Mutant Early-Passage Cultures.

Mikhail E Shmelev, Vladislav M Farniev, Nikita A Shved

Pageof 1